Laboratory Products
SpectraMax® i3: The Multi-Mode Microplate Detection Platform that evolves over time
Apr 03 2013
The SpectraMax® i3 is Molecular Devices latest multi-mode microplate reader which delivers several applications including; Ultra-Violet to visible absorbance detection, fluorescence intensity and multi-colour luminescence. There is the option to add user-installable cartridges as your research needs evolve such as HTRF®, AlphaScreen® and Fluorescence Polarisation assays as well as cellular imaging, (with the SpectraMax® MiniMax™) increasing the instruments flexibility. This highly sensitive instrument accommodates the budget and throughput needs of both small and large laboratories alike.
The SpectraMax® i3 Platform's base system features an integrated optical system enabling top and bottom reads for 6-, 384- well microplates and launches with three broad detection modes: luminescence, absorbance, and fluorescence. Patented user-exchangeable cartridge design expands the system's detection capability making it highly versatile, and able to offer application options far exceeding those of standard readers.
Using a combination of a flash lamp for spectral flexibility and light emitting diodes (LEDs) for excitation power, Molecular Devices has developed the patent-pending Spectral Fusion™ Illumination to deliver wavelength flexibility whilst maximizing signal strength, ultimately increasing overall performance.
Data from the SpectraMax® i3 System is captured and analysed using Molecular Devices' proprietary, industry-leading SoftMax® Pro Software. The newly updated interface and Spectral Optimization Wizard simplifies the workflow and provides powerful data analysis features, eliminating the need for training on additional software. The SpectraMax® i3 System is also available for use in GMP and GLP labs when used with the SoftMax® Pro 6.3 GxP Microplate Data Compliance Software. This new user interface and powerful data analysis package simplifies the set-up of the SpectraMax® i3 platform, getting you to your results much faster!
For more information and to see a video of the SpectraMax® i3 in action CLICK HERE
SpectraMax® MiniMax™ Imaging Cytometer
When is the last time you inspected your cells and ran an assay on the same instrument? With the user-upgradable imaging cytometer option, turn your SpectraMax® i3 microplate reader into a cellular imager and unlock a new world of applications.
The MiniMax™ Imaging Cytometer module adds first of its kind cellular imaging to a multi-mode detection platform, enabling fluorescence and bright field cellular imaging. Combining cellular imaging with microplate-based applications offers new ways for scientists to compress their workflows and increase efficiency.
For more information on the SpectraMax® MiniMax™ Imaging cytometer CLICK HERE
To download datasheets for the SpectraMax® i3 and SpectraMax® MiniMax™ CLICK HERE
Key benefits include:
- User Upgradeability:
Expand the 3-mode base system with additional application cartridges for FP, HTRF®, AlphaScreen® assays and cellular imaging. These user-installable cartridges prevent the need for system down time or service engineers.
- SpectraMax® MiniMax™ Imaging Cytometer:
Simplifies complex imaging workflows by visualising cell morphology changes on top of well-based intensity readings
- Spectral Fusion™ Illumination:
Delivers high-powered full spectrum light source for increased fluorescence performance across the entire excitation range
- Expanded Dynamic Range:
Sophisticated engineering delivers optimal sensitivity and maximises signal range
Imagine the SpectraMax® i3 in your lab today and begin to realise what this system will bring to your research!
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan